Clinical trials
Completed Phase 3 Anemia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
249 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 5 |
| 2001 | 4 |
| 2002 | 9 |
| 2003 | 13 |
| 2004 | 27 |
| 2005 | 18 |
| 2006 | 11 |
| 2007 | 18 |
| 2008 | 20 |
| 2009 | 8 |
| 2010 | 5 |
| 2011 | 6 |
| 2012 | 7 |
| 2013 | 3 |
| 2014 | 9 |
| 2015 | 8 |
| 2016 | 19 |
| 2017 | 11 |
| 2018 | 11 |
| 2019 | 6 |
| 2020 | 4 |
| 2021 | 6 |
| 2022 | 1 |
| 2023 | 3 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 249 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hoffmann-La Roche | 36 |
| Amgen | 23 |
| Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 16 |
| American Regent, Inc. | 15 |
| GlaxoSmithKline | 9 |
| Akebia Therapeutics | 6 |
| Bayer | 5 |
| Kyntra Bio | 5 |
| London School of Hygiene and Tropical Medicine | 5 |
| Novartis Pharmaceuticals | 5 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Anemia | 249 |
| Renal Insufficiency, Chronic | 55 |
| Kidney Failure, Chronic | 15 |
| Neoplasms | 14 |
| Anemia, Iron-Deficiency | 13 |
| Renal Insufficiency | 12 |
| Iron Deficiencies | 11 |
| Kidney Diseases | 11 |
| Multiple Myeloma | 8 |
| Myelodysplastic Syndromes | 8 |
Trials
Showing 1 to 25 of 249. Each trial links to its page on Pharma Observatory.
149 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.